The potential for targeting oncogenic WNT/β-catenin signaling in therapy

被引：22

作者：

Ewan, Kenneth B. R. ^{[1
]}

Dale, Trevor C. ^{[1
]}

机构：

[1] Sch Biosci, Carshalton CF10 3US, Surrey, England

来源：

CURRENT DRUG TARGETS | 2008年 / 9卷 / 07期

基金：

英国生物技术与生命科学研究理事会;

关键词：

Wnt; beta-catenin; signaling; dysregulation; cancer; therapy;

D O I：

10.2174/138945008784911787

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

There has been a surge of interest in the therapeutic targeting of the Wnt pathway following the demonstration that it is activated in a wide variety of tumors and that blocking aberrant signaling promoted tumor cell apoptosis or differentiation. This review describes recent therapeutic approaches and discusses potential opportunities for intervention at multiple levels within the Wnt pathway.

引用

收藏

页码：532 / 547

页数：16

相关论文

共 273 条

[51] Functional genomic analysis of the Wnt-Wingless signaling pathway [J].

DasGupta, R ;

Kaykas, A ;

Moon, RT ;

Perrimon, N .

SCIENCE, 2005, 308 (5723) :826-833

[52] Casein kinase 1γ couples Wnt receptor activation to cytoplasmic signal transduction [J].

Davidson, G ;

Wu, W ;

Shen, JL ;

Bilic, J ;

Fenger, U ;

Stannek, P ;

Glinka, A ;

Niehrs, C .

NATURE, 2005, 438 (7069) :867-872

[53] Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1α signaling in human mammary epithelial cells [J].

Dejmek, Janna ;

Safholm, Annette ;

Nielsen, Christian Kamp ;

Andersson, Tommy ;

Leandersson, Karin .

MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (16) :6024-6036

[54] The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition [J].

Dissanayake, Samudra K. ;

Wade, Michael ;

Johnson, Carrie E. ;

O'Connell, Michael P. ;

Leotlela, Poloko D. ;

French, Amanda D. ;

Shah, Kavita V. ;

Hewitt, Kyle J. ;

Rosenthal, Devin T. ;

Indig, Fred E. ;

Jiang, Yuan ;

Nickoloff, Brian J. ;

Taub, Dennis D. ;

Trent, Jeffrey M. ;

Moon, Randall T. ;

Bittner, Michael ;

Weeraratna, Ashani T. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (23) :17259-17271

[55]

Duval A, 1999, CANCER RES, V59, P4213

[56] Targeting the active β-catenin pathway to treat cancer cells [J].

Dvory-Sobol, Hadas ;

Sagiv, Eyal ;

Kazanov, Diana ;

Ben-Ze'ev, Avri ;

Arber, Nadir .

MOLECULAR CANCER THERAPEUTICS, 2006, 5 (11) :2861-2871

[57] Cross-regulation of β-catenin-LEF/TCF and retinoid signaling pathways [J].

Easwaran, V ;

Pishvaian, M ;

Salimuddin ;

Byers, S .

CURRENT BIOLOGY, 1999, 9 (23) :1415-1418

[58] Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors [J].

El-Tanani, M ;

Fernig, DG ;

Barraclough, R ;

Green, C ;

Rudland, P .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) :41675-41682

[59] A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription [J].

Emami, KH ;

Nguyen, C ;

Ma, H ;

Kim, DH ;

Jeong, KW ;

Eguchi, M ;

Moon, RT ;

Teo, JL ;

Oh, SW ;

Kim, HY ;

Moon, SH ;

Ha, JR ;

Kahn, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (34) :12682-12687

[60] Phosphorylation of β-catenin by AKT promotes β-catenin transcriptional activity [J].

Fang, Dexing ;

Hawke, David ;

Zheng, Yanhua ;

Xia, Yan ;

Meisenhelder, Jill ;

Nika, Heinz ;

Mills, Gordon B. ;

Kobayashi, Ryuji ;

Hunter, Tony ;

Lu, Zhimin .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (15) :11221-11229

← 1 2 3 4 5 6 7 8 9 10 →